Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | BTK | Q06187 | 2/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22755022 | 0.91 | LIPG (0.40) | LIPGBTKBACE1NPC1RAB9A | |
| SCHEMBL22755112 | 0.88 | LIPG (0.43) | LIPGBACE1NPC1RAB9A | |
| SCHEMBL22755249 | 0.88 | LIPG (0.43) | LIPGBACE1NPC1RAB9A | |
| SCHEMBL22755092 | 0.84 | BACE1 (0.41) | BTKBACE1NPC1RAB9A | |
| SCHEMBL22755113 | 0.84 | ADORA2A (0.48) | ALDH1A1L3MBTL1BACE1NPC1RAB9A | |
| SCHEMBL22755067 | 0.83 | MDM4 (0.46) | ALDH1A1BACE1NPC1RAB9A | |
| SCHEMBL22754845 | 0.83 | NPC1 (0.50) | ALDH1A1L3MBTL1BACE1NPC1RAB9A | |
| SCHEMBL22755262 | 0.82 | SSTR4 (0.47) | ALDH1A1BTKBACE1NPC1RAB9A | |
| SCHEMBL22755082 | 0.80 | ADORA2A (0.38) | ALDH1A1BTKBACE1NPC1RAB9A | |
| SCHEMBL22755311 | 0.79 | MAPK14 (0.39) | ALDH1A1BTKBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3747885-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2020-12-09 | — | — | EP | disclosed |